title: Guillain-Barré syndrome following adalimumab treatment.
authors.forename: Stefania
authors.initials: S
authors.lastname: Manganelli
authors.forename: Marco
authors.initials: M
authors.lastname: Rossi
authors.forename: Marco
authors.initials: M
authors.lastname: Tuccori
authors.forename: Mauro
authors.initials: M
authors.lastname: Galeazzi
mesh_terms: D000068879:Adalimumab; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D020275:Guillain-Barre Syndrome / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab